One of Cystic Fibrosis Foundation's active volunteers to carry Olympic Torch in Calgary

Coca-Cola's Liz Burns to Run in Honor of People With Cystic Fibrosis

One of the Cystic Fibrosis Foundation's most active volunteers will carry the Olympic Torch today in Calgary as it makes its way to Vancouver for the Opening Ceremony of the 2010 Olympic Winter Games.

Liz Burns, incoming board president for the Foundation's Georgia Chapter, has helped raise more than $600,000 for CF research, care and education programs. She is a senior national sales executive for Coca-Cola North America.

"Liz is a passionate and devoted volunteer, and we are thrilled she will carry the Olympic Torch in honor of people with cystic fibrosis and raise more awareness about this devastating disease," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. "We thank Coca-Cola for selecting Liz for this honor and supporting her mission and ours to find a cure and change the lives of every person with cystic fibrosis."

Cystic fibrosis is a fatal genetic disease that causes life-threatening lung infections and premature death, and affects about 70,000 people worldwide.

Burns is scheduled to carry the torch at 4:42 p.m. M.T. today, and is one of 20 U.S. Torchbearers selected by Coca-Cola for their commitment to create meaningful and enduring change in local and global communities. The Olympic Torch Relay lasts for 106 days, covers more than 27,000 miles and links more than 1,000 communities in Canada. The Olympics begin Feb. 12, 2010.

Burns was named "Volunteer of the Year" by the Foundation's Georgia Chapter in 2008. She chairs one of the Foundation's largest fundraising events, called Chocolate, an annual gala held in Atlanta.

The Foundation has fueled dramatic improvements in research and care that have significantly changed the prognosis for people with CF. The predicted median age of survival for people with CF has increased to more than 37 years — more than double what it was 25 years ago.

SOURCE Cystic Fibrosis Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis